Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 7, 2013 - Issue
Submit an article Journal homepage
516
Views
91
CrossRef citations to date
0
Altmetric
Review

Aflibercept in wet AMD: specific role and optimal use

F Semeraro1 Department of Medical and Surgical Specialties, Radiological Specialties and Public Health, Ophthalmology Clinic, University of Brescia, Brescia, ItalyCorrespondence[email protected]
,
F Morescalchi1 Department of Medical and Surgical Specialties, Radiological Specialties and Public Health, Ophthalmology Clinic, University of Brescia, Brescia, Italy
,
S Duse1 Department of Medical and Surgical Specialties, Radiological Specialties and Public Health, Ophthalmology Clinic, University of Brescia, Brescia, Italy
,
F Parmeggiani2 Department of Ophthalmology, University of Ferrara, Ferrara, Italy
,
E Gambicorti1 Department of Medical and Surgical Specialties, Radiological Specialties and Public Health, Ophthalmology Clinic, University of Brescia, Brescia, Italy
&
C Costagliola3 Department of Health Science, Ophthalmology Clinic, University of Molise, Campobasso, Italy
Pages 711-722 | Published online: 05 Aug 2013

Citations (91)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (21)

Laura Bujoreanu Bezman, Carmen Tiutiuca, Geanina Totolici, Nicoleta Carneciu, Florin Ciprian Bujoreanu, Diana Andreea Ciortea, Elena Niculet, Ana Fulga, Anamaria Madalina Alexandru, Daniela Jicman Stan & Aurel Nechita. (2023) Latest Trends in Retinopathy of Prematurity: Research on Risk Factors, Diagnostic Methods and Therapies. International Journal of General Medicine 16, pages 937-949.
Read now
Rohit Bisht, Sonali Nirmal, Rupesh Agrawal, Gaurav K. Jain & Jayabalan Nirmal. (2021) Injectable in-situ gel depot system for targeted delivery of biologics to the retina. Journal of Drug Targeting 29:1, pages 46-59.
Read now
Jaycob Avaylon, Sol Lee & Ron P Gallemore. (2020) Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration. International Medical Case Reports Journal 13, pages 145-152.
Read now
Pingting Zhong, Miao He, Honghua Yu, Qiaowei Wu, Qingsheng Peng, Manqing Huang, Yunlian Xue & Xiaohong Yang. (2020) A Meta-Analysis of Cardiovascular Events Associated with Intravitreal Anti-VEGF Treatment in Patients with Retinal Vein Occlusion. Current Eye Research 45:5, pages 615-622.
Read now
Ayna Sariyeva ismayılov, Ebru Esen, Selçuk Sızmaz & Ayşe Nihal Demircan. (2019) Aflibercept therapy in eyes with neovascular age‐related macular degeneration and its effect on choroidal thickness. Clinical and Experimental Optometry 102:6, pages 617-620.
Read now
Ciro Costagliola, Francesco Morescalchi, Sarah Duse, Davide Romano, Giuseppina Mazza, Francesco Parmeggiani, Silvia Bartollino & Francesco Semeraro. (2019) Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update. Expert Opinion on Drug Safety 18:9, pages 803-815.
Read now
Wenqiang Liu, Bao-Shiang Lee, William F. Mieler & Jennifer J. Kang-Mieler. (2019) Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro. Current Eye Research 44:3, pages 264-274.
Read now
Olivia Cundy, Mital Shah & Susan M. Downes. (2018) Intravitreal aflibercept: its role in treatment of neovascular age-related macular degeneration. Expert Review of Ophthalmology 13:2, pages 75-86.
Read now
Andrii R Korol, Oleksandra Zborovska, Taras Kustryn, Oleksandra Dorokhova & Nataliya Pasyechnikova. (2017) Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study. Clinical Ophthalmology 11, pages 1315-1320.
Read now
Rami M. Alzhrani, Qasim Alhadidi, Rinda Devi Bachu, Zahoor Shah, Surajit Dey & Sai HS. Boddu. (2017) Tanshinone IIA Inhibits VEGF Secretion and HIF-1α Expression in Cultured Human Retinal Pigment Epithelial Cells under Hypoxia. Current Eye Research 42:12, pages 1667-1673.
Read now
Wenbo Li, Lijie Dong, Minwang Ma, Bojie Hu, Zhenyu Lu, Xun Liu, Juping Liu & Xiaorong Li. (2016) Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration. Drug Design, Development and Therapy 10, pages 3415-3423.
Read now
Muhammad Hassan, Rubbia Afridi, Mohammad Ali Sadiq, Mohamed Kamel Soliman, Aniruddha Agarwal, Yasir Jamal Sepah, Diana V. Do & Quan Dong Nguyen. (2016) The role of Aflibercept in the management of age-related macular degeneration. Expert Opinion on Biological Therapy 16:5, pages 699-709.
Read now
Focke Ziemssen, Bianka Sobolewska, Heidrun Deissler & Helmut Deissler. (2016) Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues. Expert Opinion on Drug Safety 15:1, pages 75-87.
Read now
Arshad M Khanani. (2015) Clinical experience with fixed bimonthly aflibercept dosing in treatment-experienced patients with neovascular age-related macular degeneration. Clinical Ophthalmology 9, pages 1315-1320.
Read now
Chandrakumar Balaratnasingam, Elona Dhrami-Gavazi, Jesse T McCann, Quraish Ghadiali & K Bailey Freund. (2015) Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration. Clinical Ophthalmology 9, pages 2355-2371.
Read now
Xiaodan Jiang, Huibin Lv, Weiqiang Qiu, Ziyuan Liu, Xuemin Li & Wei Wang. (2015) Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye. Drug Design, Development and Therapy 9, pages 3043-3050.
Read now
Yu Di, Yiou Zhang, Hongwei Yang, Aiyuan Wang & Xiaolong Chen. (2015) The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt–VEGF signaling pathway. Drug Design, Development and Therapy 9, pages 2463-2473.
Read now
Mohammad Hossein Yazdi, Mohammad Ali Faramarzi, Shekoufeh Nikfar, Khalil Ghasemi Falavarjani & Mohammad Abdollahi. (2015) Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration. Expert Opinion on Biological Therapy 15:9, pages 1349-1358.
Read now
Martina Santarelli, Laura Diplotti, Francesco Samassa, Daniele Veritti, Baruch D Kuppermann & Paolo Lanzetta. (2015) Advances in pharmacotherapy for wet age-related macular degeneration. Expert Opinion on Pharmacotherapy 16:12, pages 1769-1781.
Read now
Chris Spahr, Stone D-H Shi & Hsieng S Lu. (2014) O-Glycosylation of glycine-serine linkers in recombinant Fc-fusion proteins. mAbs 6:4, pages 904-914.
Read now
Francesco Semeraro, Francesco Morescalchi, Sarah Duse, Elena Gambicorti, Mario R Romano & Ciro Costagliola. (2014) Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview. Expert Opinion on Drug Safety 13:6, pages 785-802.
Read now

Articles from other publishers (70)

Shiyu Dong, Linzhi Chen, Achim Sauer & Lars Dittus. (2023) LC/MS Assessment of Glycoform Clearance of A Biotherapeutic MAb in Rabbit Ocular Tissues. Journal of Pharmaceutical Sciences 112:8, pages 2285-2291.
Crossref
Yu Wu, Lalitkumar K. Vora, Ryan F. Donnelly & Thakur Raghu Raj Singh. (2022) Rapidly dissolving bilayer microneedles enabling minimally invasive and efficient protein delivery to the posterior segment of the eye. Drug Delivery and Translational Research 13:8, pages 2142-2158.
Crossref
Vaibhavi Srivastava, Padakanti Sandeep Chary, Naveen Rajana, Ekta R. Pardhi, Vivek Singh, Dharmendra Khatri, Shashi Bala Singh & Neelesh Kumar Mehra. (2023) Complex ophthalmic formulation technologies: Advancement and future perspectives. Journal of Drug Delivery Science and Technology 82, pages 104317.
Crossref
Regina Lukacs, Miklos Schneider, Zoltan Zsolt Nagy, Gabor Laszlo Sandor, Kinga Kaan, Antonia Asztalos, Lajos Enyedi, Gyorgy Pek, Gyorgy Barcsay, Antal Szabo, Agnes Borbandy, Illes Kovacs, Miklos Denes Resch & Andras Papp. (2023) Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration. BMC Ophthalmology 23:1.
Crossref
Jared S. Nielsen, Carter L. Roberts, David D. Saggau & Kyle J. Alliman. (2023) High-Dose Aflibercept for Neovascular AMD and DME in Suboptimal Responders to Standard-Dose Aflibercept. Journal of VitreoRetinal Diseases 7:2, pages 116-124.
Crossref
Grazyna Palczewska, Maciej Wojtkowski & Krzysztof Palczewski. (2023) From mouse to human: Accessing the biochemistry of vision in vivo by two-photon excitation. Progress in Retinal and Eye Research 93, pages 101170.
Crossref
Sara Aly Attia & J. Andrew MacKay. (2022) Protein and polypeptide mediated delivery to the eye. Advanced Drug Delivery Reviews 188, pages 114441.
Crossref
Işıl Merve TORUN, Erkan DUMAN & Nursel Melda YENEREL. (2022) Ranibizumab Tedavisine Dirençli Tip 1 Koroidal Neovasküler Membranlı Olgularda İntravitreal Aflibercept Uygulaması SonuçlarımızIntravitreal Aflibercept Application in Patients with Type 1 Choroidal Neovascular Membrane Resistant to Ranibizumab Treatment Results. Batı Karadeniz Tıp Dergisi 6:2, pages 150-157.
Crossref
Sławomir Liberski, Małgorzata Wichrowska & Jarosław Kocięcki. (2022) Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review. International Journal of Molecular Sciences 23:16, pages 9424.
Crossref
Dang Tran Dat, Nguyen Do Thi Ngoc Hien, Nguyen Nhu Quan, Mai Quoc Tung, Hoang Chi Tam & Bui Viet Hung. (2022) Current Trends in Clinical Characteristics, Diagnosis, and Treatment of Polypoidal Choroidal Vasculopathy: A Perspective from Vietnam. Journal of Clinical Medicine 11:16, pages 4678.
Crossref
Kenichiro Mori, Keijiro Ishikawa, Yosuke Fukuda, Rui Ji, Iori Wada, Yuki Kubo, Masato Akiyama, Shoji Notomi, Yusuke Murakami, Shintaro Nakao, Satoshi Arakawa, Satomi Shiose, Toshio Hisatomi, Shigeo Yoshida, Ram Kannan & Koh-Hei Sonoda. (2022) TNFRSF10A downregulation induces retinal pigment epithelium degeneration during the pathogenesis of age-related macular degeneration and central serous chorioretinopathy . Human Molecular Genetics 31:13, pages 2194-2206.
Crossref
Natsuka Kimura, Hidenori Takahashi, Shinichi Sakamoto, Yasuo Yanagi, Nozomi Maeshima, Ayaka Minamimoto, Noriko Iwamoto, Takashi Shimada, Ryozo Nagai & Kenichi Aizawa. (2022) Microvolume Analysis of Aflibercept in Aqueous Humor Using Mass Spectrometry. Translational Vision Science & Technology 11:6, pages 7.
Crossref
Nada O. Taher, Abdullah A. Ghaddaf, Sarah A. Al-Ghamdi, Jumanah J. Homsi, Bandar J. Al-Harbi, Lugean K. Alomari & Hashem S. Almarzouki. (2022) Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis. Frontiers in Medicine 9.
Crossref
Miriam Bobadilla, Ana Pariente, Ana I. Oca, Rafael Peláez, Álvaro Pérez-Sala & Ignacio M. Larráyoz. (2022) Biomarkers as Predictive Factors of Anti-VEGF Response. Biomedicines 10:5, pages 1003.
Crossref
Saroj SahdevPurva S. Date. (2021) PARADIGM SHIFT IN MANAGEMENT OF ROP: FROM LASERS TO ANTI-VEGF THERAPY. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 57-60.
Crossref
Maitri Bhatt & Pravin Shende. (2021) Modulated approaches for strategic transportation of proteins and peptides via ocular route. Journal of Drug Delivery Science and Technology 66, pages 102835.
Crossref
Charis Rousou, Carl C. L. Schuurmans, Arto Urtti, Enrico Mastrobattista, Gert Storm, Chrit Moonen, Kai Kaarniranta & Roel Deckers. (2021) Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research towards Clinical Application. Pharmaceutics 13:11, pages 1782.
Crossref
Xing Li, Shichang Cai, Zhiming He, James Reilly, Zhihong Zeng, Niall Strang & Xinhua Shu. (2021) Metabolomics in Retinal Diseases: An Update. Biology 10:10, pages 944.
Crossref
Paulina Jakubiak, Rubén Alvarez-Sánchez, Matthias Fueth, Olaf Broders, Hubert Kettenberger, Kay Stubenrauch & Antonello Caruso. (2021) Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats. Molecular Pharmaceutics 18:6, pages 2208-2217.
Crossref
Michał Wiciński, Małgorzata Seredyka-Burduk, Sławomir Liberski, Daria Marczak, Magdalena Pol, Bartosz Malinowski, Katarzyna Pawlak-Osińska & Bartlomiej J. Kaluzny. (2021) Evaluation of Blood Coagulation Parameters and ADMA, NO, IL-6, and IL-18 Serum Levels in Patients with Neovascular AMD before, during, and after the Initial Loading Phase of Intravitreal Aflibercept. Life 11:5, pages 441.
Crossref
Ruti Sella, Meydan Ben Ishai, Eitan Livny, Yoav Nahum & Irit Bahar. (2021) Subconjunctival Aflibercept for the Treatment of Formed Corneal Neovascularization. Eye & Contact Lens: Science & Clinical Practice 47:4, pages 180-184.
Crossref
Kalishankar DasDr.Dr., Athokpam PoireitonDr.Dr. & Sneha BhowmickDr.Dr.. (2021) INTRAVITREAL RANIBIZUMAB INJECTION AS TREATMENT IN PATIENTS WITH TYPE 1 RETINOPATHY OF PREMATURITY. INDIAN JOURNAL OF APPLIED RESEARCH, pages 13-15.
Crossref
Claudia Riccardi, Ettore Napolitano, Chiara Platella, Domenica Musumeci, Mariarosa A. B. Melone & Daniela Montesarchio. (2020) Anti‐VEGF DNA‐based aptamers in cancer therapeutics and diagnostics. Medicinal Research Reviews 41:1, pages 464-506.
Crossref
Sydney Menikheim, Joshua Leckron, Steven Bernstein & Erin B. Lavik. (2020) On-Demand and Long-Term Drug Delivery from Degradable Nanocapsules. ACS Applied Bio Materials 3:11, pages 7369-7375.
Crossref
Blessing C. Ilochonwu, Arto Urtti, Wim E. Hennink & Tina Vermonden. (2020) Intravitreal hydrogels for sustained release of therapeutic proteins. Journal of Controlled Release 326, pages 419-441.
Crossref
Jordi Monés & Marc Biarnés. (2019) Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy. European Journal of Ophthalmology 30:5, pages 1082-1090.
Crossref
Alireza Baradaran-Rafii, Masoumeh Sarvari, Sepideh Alavi-Moghadam, Moloud Payab, Parisa Goodarzi, Hamid Reza Aghayan, Bagher Larijani, Mostafa Rezaei-Tavirani, Mahmood Biglar & Babak Arjmand. (2020) Cell-based approaches towards treating age-related macular degeneration. Cell and Tissue Banking 21:3, pages 339-347.
Crossref
Simon Hauri, Paulina Jakubiak, Matthias Fueth, Stefan Dengl, Sara Belli, Rubén Alvarez-Sánchez & Antonello Caruso. (2020) Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin. Pharmaceutics 12:9, pages 810.
Crossref
Beata Urban, Magdalena Szwabowicz & Alina Bakunowicz-Łazarczyk. (2020) Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration. Journal of Ophthalmology 2020, pages 1-7.
Crossref
Sara J. Haug, Doan Luong Hien, Gunay Uludag, Than Trong Tuong Ngoc, Sherin Lajevardi, M. Sohail Halim, Yasir J. Sepah, Diana V. Do & Arshad M. Khanani. (2020) Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration. American Journal of Ophthalmology Case Reports 18, pages 100680.
Crossref
Victor A. Eng, Nadim Rayess, Huy V. Nguyen & Theodore Leng. (2020) Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration. PLOS ONE 15:5, pages e0232353.
Crossref
Georgios D Panos. (2020) Advances in intravitreal therapy and implants: where are we now?. Therapeutic Delivery 11:2, pages 69-73.
Crossref
Georgios D. Panos. (2018) Evolution of intravitreal therapy for retinal and macular disorders. Journal of International Medical Research 48:1, pages 030006051877141.
Crossref
Anindya Samanta, Aamir A. Aziz, Mahima Jhingan, Sumit Randhir Singh, Arshad M. Khanani & Jay Chhablani. (2020) Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020. Asia-Pacific Journal of Ophthalmology 9:3, pages 250-259.
Crossref
Jing Jiang, Ling Wang, Xiangying Kou, Zhihao Liu, Min Huang, Hongzhen Li & Chuandong Wu. (2020) In vivo characterization of RC28-E, a fusion protein targeting VEGF and bFGF: Pharmacokinetics and ocular distribution in primates. Experimental Eye Research 190, pages 107823.
Crossref
Aamir A. Aziz, Ibrahim Khanani, Fawwaz A. Siddiqui, Ryan N. Constantine & Arshad M. Khanani. 2020. Choroidal Neovascularization. Choroidal Neovascularization 425 433 .
Wonjin Park, Yi-Yong Baek, Joohwan Kim, Dong Hyun Jo, Seunghwan Choi, Jin Hyoung Kim, Taesam Kim, Suji Kim, Minsik Park, Ji Yoon Kim, Moo-Ho Won, Kwon-Soo Ha, Jeong Hun Kim, Young-Guen Kwon & Young-Myeong Kim. (2019) Arg-Leu-Tyr-Glu Suppresses Retinal Endothelial Permeability and Choroidal Neovascularization by Inhibiting the VEGF Receptor 2 Signaling Pathway. Biomolecules & Therapeutics 27:5, pages 474-483.
Crossref
Hyun Goo Kang, Eun Young Choi, Suk Ho Byeon, Sung Soo Kim, Hyoung Jun Koh, Sung Chul Lee & Min Kim. (2019) Intravitreal ranibizumab versus laser photocoagulation for retinopathy of prematurity: efficacy, anatomical outcomes and safety. British Journal of Ophthalmology 103:9, pages 1332-1336.
Crossref
Zois Papadopoulos. (2019) Aflibercept: A review of its effect on the treatment of exudative age-related macular degeneration. European Journal of Ophthalmology 29:4, pages 368-378.
Crossref
S. K. Haßel & G. Mayer. (2019) Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?. Molecular Diagnosis & Therapy 23:3, pages 301-309.
Crossref
Allison Low, Ambar Faridi, Kavita V Bhavsar, Glenn C Cockerham, Michele Freeman, Rochelle Fu, Robin Paynter, Karli Kondo & Devan Kansagara. (2019) Comparative effectiveness and harms of intravitreal antivascular endothelial growth factor agents for three retinal conditions: a systematic review and meta-analysis. British Journal of Ophthalmology 103:4, pages 442-451.
Crossref
Asghar Fallah, Ali Sadeghinia, Houman Kahroba, Amin Samadi, Hamid Reza Heidari, Behzad Bradaran, Sirous Zeinali & Ommoleila Molavi. (2019) Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases. Biomedicine & Pharmacotherapy 110, pages 775-785.
Crossref
Noritaka Hashii & Akiko Ishii-Watabe. (2018) Site-specific <i>O</i>-Glycosylation Analysis of Therapeutic Fc-fusion Protein by Mass Spectrometry質量分析によるFc融合タンパク質医薬品の<i>O</i>-結合型糖鎖部位特異的解析. YAKUGAKU ZASSHI 138:12, pages 1483-1494.
Crossref
Yih-Jing Lee, Chia-Ying Ke, Ni Tien & Po-Kang Lin. (2018) Hyperhomocysteinemia Causes Chorioretinal Angiogenesis with Placental Growth Factor Upregulation. Scientific Reports 8:1.
Crossref
B. Sobolewska, J. Golenko, S. Poeschel, C. Grimmel, A. Gatsiou, K. Sopova, T. Biedermann, K. Schenke-Layland, K. Stellos & F. Ziemssen. (2018) Influence of aflibercept on platelet activation profile. Experimental Eye Research 175, pages 166-172.
Crossref
Dario Ruiz Ciancio, Mauricio Vargas, William Thiel, Martin Bruno, Paloma Giangrande & María Mestre. (2018) Aptamers as Diagnostic Tools in Cancer. Pharmaceuticals 11:3, pages 86.
Crossref
Erik Van Kampen, Craig Vandervelden, Amir Fakhari, Jian Qian, Cory Berkland & Stevin H. Gehrke. (2018) Design of Hollow Hyaluronic Acid Cylinders for Sustained Intravitreal Protein Delivery. Journal of Pharmaceutical Sciences 107:9, pages 2354-2365.
Crossref
Jung Kee Min, Seunghwan Lee, Jong Hoon Park, Je Moon Woo & Hyun Seung Yang. (2018) Effects of intravitreal aflibercept and ranibizumab on retinal vessel diameter measured using fluorescein angiography. Acta Ophthalmologica 96:4, pages e546-e547.
Crossref
Abhirup Mandal, Dhananjay Pal, Vibhuti Agrahari, Hoang My Trinh, Mary Joseph & Ashim K. Mitra. (2018) Ocular delivery of proteins and peptides: Challenges and novel formulation approaches. Advanced Drug Delivery Reviews 126, pages 67-95.
Crossref
Hyun Goo KangEun Young ChoiSuk Ho ByeonSung Soo KimHyoung Jun KohSung Chul LeeMin Kim. (2018) Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes. Korean Journal of Ophthalmology 32:6, pages 451.
Crossref
Nithya Subramanian, Akilandeswari Balachandran & Krishnakumar Subramanian. 2018. Gene and Cell Therapy: Biology and Applications. Gene and Cell Therapy: Biology and Applications 147 194 .
Qiujing Huang, Qi Zhang, Ping Fei, Yu Xu, Jiao Lyu, Xunda Ji, Jie Peng, Yi-an Li & Peiquan Zhao. (2017) Ranibizumab Injection as Primary Treatment in Patients with Retinopathy of Prematurity. Ophthalmology 124:8, pages 1156-1164.
Crossref
Norihiro Nagai, Mari Ibuki, Hajime Shinoda, Kaori Kameyama, Kazuo Tsubota & Yoko Ozawa. (2017) Maculopapular rash after intravitreal injection of an antivascular endothelial growth factor, aflibercept, for treating age-related macular degeneration. Medicine 96:21, pages e6965.
Crossref
Weiyong Shen, Belinda Yau, So-Ra Lee, Ling Zhu, Michelle Yam & Mark Gillies. (2017) Effects of Ranibizumab and Aflibercept on Human Müller Cells and Photoreceptors under Stress Conditions. International Journal of Molecular Sciences 18:3, pages 533.
Crossref
Chiara M. Eandi, Camilla Alovisi, Ugo De Sanctis & Federico M. Grignolo. (2016) Treatment for neovascular age related macular degeneration: The state of the art. European Journal of Pharmacology 787, pages 78-83.
Crossref
Xiaozhi Zhao, Wei Chen, Liyuan Ge, Wei Jiang, Bo Tang, Qing Zhang, Xiaoyu Xu, Chong Wang, Lin Cao & Hongqian Guo. (2016) Transient expression of Fc-fused human glycoprotein 130 in Expi293F suspension cells. Protein Expression and Purification 124, pages 41-47.
Crossref
Norihiro Nagai, Misa Suzuki, Atsuro Uchida, Toshihide Kurihara, Mamoru Kamoshita, Sakiko Minami, Hajime Shinoda, Kazuo Tsubota & Yoko Ozawa. (2016) Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment. Scientific Reports 6:1.
Crossref
Orly Gal-Or, Eitan Livny, Ruti Sella, Yael Nisgav, Dov Weinberger, Tami Livnat & Irit Bahar. (2016) Efficacy of Subconjunctival Aflibercept Versus Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model. Cornea 35:7, pages 991-996.
Crossref
Ruti Sella, Orly Gal-Or, Eitan Livny, Mor Dachbash, Yael Nisgav, Dov Weinberger, Tami Livnat & Irit Bahar. (2016) Efficacy of topical aflibercept versus topical bevacizumab for the prevention of corneal neovascularization in a rat model. Experimental Eye Research 146, pages 224-232.
Crossref
Anand Giddabasappa, Kush Lalwani, Rand Norberg, Hovhannes J. Gukasyan, David Paterson, Ronald A. Schachar, Kay Rittenhouse, Karen Klamerus, Lydia Mosyak & Jeetendra Eswaraka. (2016) Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models. Experimental Eye Research 145, pages 373-379.
Crossref
Patricia Udaondo, David Salom, Salvador García-Delpech & Ángel Cisneros-Lanuza. (2016) Aflibercept as First-Line Therapy in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Prospective Case Series Analysis in Real-Life Clinical Practice. Ophthalmologica 236:1, pages 29-35.
Crossref
Keith E Maier & Matthew Levy. (2016) From selection hits to clinical leads: progress in aptamer discovery. Molecular Therapy - Methods & Clinical Development 3, pages 16014.
Crossref
Alfredo García-Layana, Marta S. Figueroa, Javier Araiz, José M. Ruiz-Moreno, Francisco Gómez-Ulla, Luis Arias-Barquet & Nicholas Reiter. (2015) Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept. Drugs & Aging 32:10, pages 797-807.
Crossref
L. Kodjikian, E. Fourmaux, F. Coscas, S. Dumas, C. Français, C. Morel, H. Oubraham & S. Razavi. (2015) Traitement de la dégénérescence maculaire liée à l’âge : avis d’experts et algorithme thérapeutique. Journal Français d'Ophtalmologie 38:7, pages 639-645.
Crossref
Yasha S. Modi, Carley Tanchon & Justis P. Ehlers. (2015) Comparative Safety and Tolerability of Anti-VEGF Therapy in Age-Related Macular Degeneration. Drug Safety 38:3, pages 279-293.
Crossref
K. Michalska-Małecka, A. Kabiesz, M. Nowak & D. Śpiewak. (2015) Age related macular degeneration – challenge for future: Pathogenesis and new perspectives for the treatment. European Geriatric Medicine 6:1, pages 69-75.
Crossref
João Pinheiro-Costa, José M. Costa, João N. Beato, Paulo Freitas-da-Costa, Elisete Brandão, Manuel S. Falcão, Fernando Falcão-Reis & Ângela M. Carneiro. (2015) Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice. Ophthalmologica 233:3-4, pages 155-161.
Crossref
Marialaura Madrigal, Kosagisharaf S Rao & Neil H Riordan. (2014) A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. Journal of Translational Medicine 12:1.
Crossref
C. Biagi, V. Conti, N. Montanaro, M. Melis, E. Buccellato, M. Donati, A. Covezzoli, R. Amato, L. Pazzi, M. Venegoni, A. Vaccheri & D. Motola. (2014) Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions. European Journal of Clinical Pharmacology 70:12, pages 1505-1512.
Crossref
Stijn Moens, Jermaine Goveia, Peter C. Stapor, Anna Rita Cantelmo & Peter Carmeliet. (2014) The multifaceted activity of VEGF in angiogenesis – Implications for therapy responses. Cytokine & Growth Factor Reviews 25:4, pages 473-482.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.